Results

Total Results: 402 records

Showing results for "drug".

321. Strategy 4: IDEA Discharge Planning (Tool 1) (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/engagingfamilies/strategy4/Strat4_Tool_1_IDEAL_chklst_508.pdf
     January 01, 2010 - these could have been prevented or ameliorated.1 Common post-discharge complications include adverse drug

322. Methods To Estimate the Baseline 2010 PFP National Hospital-Acquired Condition Rate (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/pfphac.pdf
     September 01, 2014 - Rate Partnership for Patients Hospital-Acquired Conditions Source Measure Adverse Drug

323. TeamSTEPPS in Long-Term Care (LTC): Financial and Safety Benefits of Implementing TeamSTEPPS in Nursing Homes and LTC Facilities
     pcmh.ahrq.gov/sites/default/files/wysiwyg/teamstepps/webinars/2013-materials/teamstepps-monthly-webinar-sept2013.pptx
     January 01, 2013 - Decreased malpractice claims Decreased insurance premiums Decreased litigation Reduced rate of adverse drug

324. 2012 CAHPS Clinician & Group Survey Database Chartbook (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2013_hp-chartbook.pdf
     January 01, 2013 - participants enrolled in a managed care health plan including both enrollees receiving prescription drug … coverage through their health plan and those that do not receive prescription drug coverage through

325. Spreadnotes (doc file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/cusptoolkit/modules/spread/spreadnotes.docx
     August 28, 2012 - ASK: · How did the pilot CUSP team make a case for their project targeting adverse drug events?

326. Platelet-Rich Plasma for Wound Care: Technology Assessment (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/prp/prp-wound-care.pdf
     September 17, 2020 - Disclaimer Food and Drug Administration (FDA) has not licensed any PRP products for any specific indications … mailto:EPC@ahrq.hhs.gov i Disclaimer: Food and Drug Administration (FDA) has not licensed any … The study of the effectiveness of the drug combination of collagen and platelet-rich plasma for the … We searched Food and Drug Administration (FDA) website, ClinicalTrials.gov, Health Canada, Medicines … Food and Drug Administration (FDA) has not licensed any PRP products for any specific indications.

327. SHARE Approach Workshop Curriculum | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/health-literacy/professional-training/shared-decision/workshop/mod3-guide.html
     September 01, 2020 - Comparing prescription drug coverage plans. Calculating premiums, co-pays, and deductibles. … Food and Drug Administration; 2011.

328. Module 27: Helping Practices Optimize EHRs for (pdf file)
     pcmh.ahrq.gov/sites/default/files/attachments/pcpf-module-27-ehr-and-pcmh.pdf
     September 01, 2015 - proactive preventative care practices  Adopt or improve value-driven care processes (e.g., generic drug …  Improve health plan contract negotiation  Improve patient safety reporting (e.g., post-market drug … information button that appears during data entry the first time a clinician selects a particular drug

329. CUSP Toolkit Spread Facilitator Notes | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/hai/cusp/modules/spread/notes.html
     December 01, 2012 - Ask: How did the pilot CUSP team make a case for their project targeting adverse drug events?

330. TeamSTEPPS® Instructor Manual: Specialty Scenarios | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/teamstepps/instructor/scenarios/ed.html
     March 01, 2014 - Clara, an experienced pharmacy technician, questions the drug dosage. Dr.

331. Health Literacy and Patient and Family Engagement: Strategic Tools to Prevent CAUTI | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/hai/cauti-tools/archived-webinars/health-literacy-slides.html
     December 01, 2017 - SHARE: More topics in this section Healthcare-Associated Infections Program Combating Antibiotic-Resistant Bacteria About the CUSP Method Decolonization – Universal and Targeted Tools Ambulatory Surgery Centers Toolkit CLABSI and …

332. Chsp-Accomplishments-Report-2021 (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/chsp/CHSP-accomplishments-report-2021.pdf
     January 01, 2021 - • An examination of the effects of the 340B Drug Pricing Program on hospital–physician consolidation … Consequences of the 340B Drug Pricing Program. New Engl J Med 2018;378:539–48. … pubmed.ncbi.nlm.nih.gov/332 84524/ King A, Schwartz L, Woloshin S 2020 A National Survey of the Frequency of Drug … Authors Year Title Journal Research Focus Link Desai S, McWilliams JM 2018 Consequences of the 340B Drug

333. How Learning Health Systems Learn: Lessons from the Field | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/learning-health-systems/how-lhs-learn.html
     May 01, 2019 - SHARE: More topics in this section Learning Health Systems Supporting Learning Health Systems Building the Workforce Exploring Learning Health Systems' Needs About our Work on Learning Health Systems Resources Lessons from the Fie…

334. Meeting Minutes, April 2019 | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/news/events/nac/2019-04-nac/nacmtg0419-minutes.html
     July 01, 2019 - has team leads and cross-agency workgroups that are responding to the HHS Secretary’s priorities in drug

335. 2014 CAHPS Health Plan Survey Database Chartbook (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/cahps/cahps-database/2014_hp-chartbook.pdf
     January 01, 2014 - participants enrolled in a managed care health plan including both enrollees receiving prescription drug … coverage through their health plan and those that do not receive prescription drug coverage through

336. 2022 National Healthcare Quality and Disparities Report Detailed Methods for Medical Expenditure Panel Survey Tables (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-meps-methods.pdf
     December 01, 2023 - 2022 National Healthcare Quality and Disparities Report Detailed Methods for Medical Expenditure Panel Survey Tables 2023 National Healthcare Quality and Disparities Report Detailed Methods for Medical Expenditure Panel Survey Tables U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research…

337. Using Pragmatic Clinical Trials to Test the Effectiveness of Patient-Centered Medical Home Models in Real-World Settings | PCMH Resource Center
     pcmh.ahrq.gov/page/using-pragmatic-clinical-trials-test-effectiveness-patient-centered-medical-home-models-real
     March 01, 2013 - health care intervention would compare the intervention to usual care, rather than the more traditional “drug

338. Using Pragmatic Clinical Trials to Test the Effectiveness of Patient-Centered Medical Home Models in Real-World Settings (pdf file)
     pcmh.ahrq.gov/sites/default/files/attachments/UsingPragmatic_032513comp.pdf
     March 01, 2013 - care intervention would compare the intervention to usual care, rather than the more traditional “drug

339. TeamSTEPPS Specialty Scenarios: ED (pdf file)
     pcmh.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/teamstepps/instructor/scenarios/ed.pdf
     March 19, 2014 - Clara, an experienced pharmacy technician, questions the drug dosage. Dr.

340. 3. Breadth and Focus Areas of Federal Agency Research Portfolios in HSR and PCR | Agency for Healthcare Research and Quality
     pcmh.ahrq.gov/healthsystemsresearch/hspc-research-study/breadth-and-focus.html
     July 01, 2021 - effective strategies to reduce medical errors and harms, such as healthcare-associated infections, adverse drug … amounts of HSR and PCR include the National Institute of Mental Health (NIMH), National Institute on Drug